Aurora Spine Announces Fourth U.S. Patent for DEXA Technology
Aurora Spine Corporation has announced the issuance of its fourth U.S. patent related to its DEXA Technology® platform. The patent, U.S. Patent No. 12,605,252 B2, enhances the company’s ability to offer bone density-matched orthopedic implants, which aim to improve the compatibility of implants with patients’ bone quality. This innovation is expected to advance personalized approaches in spinal surgery, addressing variations in patient bone density and aiming to reduce implant-related complications.
CARLSBAD, Calif., May 07, 2026 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in the development of groundbreaking medical devices for spinal surgery, today announced the issuance of its fourth U.S. patent related to Aurora’s proprietary DEXA Technology® platform.